Reactive Cutaneous Capillary Endothelial Proliferation in Esophageal Squamous Cell Carcinoma Patients Treated With Camrelizumab-Based Therapy: A Pooled Analysis of Two Phase 3 Trials.

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42577673

; Aichun Chen; Chaoyu Lin; Fan Chen; Huiyan Luo; Jia Liu; Mingming He; Ruihua Xu; Ye He; Zhaoqing Zheng; Zhiguo Hou

Aug 12, 2026